Namory Bagayoko, MD
Foot and Ankle Surgery · Anchorage, AKNPI 1891999322
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,066 of the $1,425 with a category attached, or 74.8%. 7 manufacturers reported payments, led by Arthrex at 47.0% of the total. Reporting peaked in 2020 at $701 and has fallen 68.7% since, to $219 in 2025. That places this record below the midpoint for foot and ankle surgery clinicians in AK, where the typical reported total is $1,425.
Across 20 payments — averaging $71.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$670
- Stryker$436
- Restor3d, Inc.$121
- Lifenet Health$102
- Johnson & Johnson$35
- Summit Surgical Corp.$32
- plus $30 from 1 others
What the payments were for
- Travel & lodging$36025%
- Food & beverage$1,06675%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 8 | $670 |
| Stryker(2 entities) | 6 | $436 |
| Restor3d, Inc. | 1 | $121 |
| Lifenet Health | 1 | $102 |
| Johnson & Johnson | 2 | $35 |
| Summit Surgical Corp. | 1 | $32 |
| Bioventus LLC | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,425 in reported general payments places this provider in the 50th percentile of 21 foot and ankle surgery providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 12 | $137 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Anchorage
- Regina FiaccoAnchorage$18K
- Sheryse MobleyAnchorage$15K
- Rabun FoxAnchorage$8K
- Eugene ChangAnchorage$7K
- Chloe MulliganAnchorage$4K
- Sean DunleavyAnchorage$4K
- Jennifer JansmaAnchorage$2K
- Jared KernAnchorage$2K
- Caitlin KoellingAnchorage$913
- Matt HeilalaAnchorage$679
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.